Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women.Patients and Methods Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening...
BackgroundFor women at potentially increased risk for ovarian cancer, data regarding screening and r...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for ri...
Item does not contain fulltextPURPOSE: Women with BRCA1/2 gene mutations who have completed their ch...
PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidat...
Introduction Women who carry BRCA1/2 mutations have an increased risk for breast and ovarian cancer....
ObjectivesWomen at increased genetic risk of ovarian cancer (OC) are recommended to have risk-reduci...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Germline mutations in the BRCA1 and BRCA2 genes are associated with significantly increased risks fo...
Women at high risk of ovarian cancer (file to a genetic predisposition may opt for either surveillan...
BackgroundFor women at potentially increased risk for ovarian cancer, data regarding screening and r...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Purpose Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidate...
Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for ri...
Item does not contain fulltextPURPOSE: Women with BRCA1/2 gene mutations who have completed their ch...
PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidat...
Introduction Women who carry BRCA1/2 mutations have an increased risk for breast and ovarian cancer....
ObjectivesWomen at increased genetic risk of ovarian cancer (OC) are recommended to have risk-reduci...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Germline mutations in the BRCA1 and BRCA2 genes are associated with significantly increased risks fo...
Women at high risk of ovarian cancer (file to a genetic predisposition may opt for either surveillan...
BackgroundFor women at potentially increased risk for ovarian cancer, data regarding screening and r...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...